Antisense oligonucleotides for rna editing and methods for using the same
AssigneeDeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorsRiccardo PECORI, Annette ARNOLD
Life of this patent
Estimating the term…
Loading patent…
AssigneeDeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorsRiccardo PECORI, Annette ARNOLD
Estimating the term…
The present invention concerns antisense oligonucleotides and methods for using the same. In particular, it relates to an antisense oligonucleotide having the following elements: 3′-A1-B-A2-D-A3-5′, wherein A1 is a nucleotide sequence having a length of from 6 to 16 nucleotides; B is the nucleotide cytosine; A2 is a nucleotide sequence having a length of from 33 to 37 nucleotides; D is an internal loop-forming nucleotide sequence having a length of 4 nucleotides; and A3 is a nucleotide sequence having a length of from 10 to 20 nucleotides, wherein elements A1, A2 and A3 are contiguous nucleotide sequences that are complementary to a target nucleotide sequence, and wherein the cytosine of element B forms a base-pair mismatch with adenosine in the target nucleotide sequence upon hybridization of elements A1, A2 and A3 to the target nucleotide sequence. Furthermore, the present invention relates to an expression cassette comprising a promoter sequence driving the expression of a nucleotide encoding said antisense oligonucleotide. In addition, the present invention concerns a vector comprising a nucleic acid encoding said antisense oligonucleotide or at least said one expression cassette. The present invention further envisages use of said antisense oligonucleotide, said expression cassette or the vector for editing RNA in a cultured cell or in vitro, as well as a method for editing RNA comprising contacting the RNA to be edited in cultured cell or in vitro. Moreover, the present invention relates to a pharmaceutical composition comprising the antisense oligonucleotide, the expression cassette or the vector. Further encompassed is an antisense, an expression cassette or a vector for use in treating and/or preventing a disease or disorder associated with mutated RNA. The present invention also refers to a method for treating and/or preventing a disease associated with mutated RNA.
An antisense oligonucleotide having the following elements:
(canceled)
(canceled)
Dependencies are inferred from the claim text.